Having trouble reading this email? View the web version here  |  Forward this email to a colleague

Facebook Like Button Tweet Button
European Pharmaceutical Review Follow us on Twitter
Join us on LinkedIn

Achieve right-first-time microbial identification

Next-generation, high-throughput comparative DNA sequencing system for identification of bacteria and fungi

The answer is in the DNA

Harmful bacteria and fungi can contaminate raw materials, production facilities, and even worse, branded products. The Life Technologies MicroSEQ® Rapid Microbial Identification System uses a highly accurate phylogenetic approach for microbial identification based on the sequencing of the 16S rRNA gene for bacteria or the D2 region of the large subunit for fungi and comparison of the sequences to those in its validated libraries. After sequencing the rRNA gene, the MicroSEQ® system automatically compares the results to validated sequences in the MicroSEQ® microbial libraries. The results are ranked according to genetic distance of the reference sequences to the sample and displayed on the system monitor along with a phylogenetic tree. The system includes the largest fully validated bacterial and fungal libraries. The bacterial library includes over 2000 species, including Staphylococcus spp., Bacillus spp., coryneforms, mycobacteria, and Gram-negative non-fermenters. The library for fungal species includes over 1100 entries. Both are frequently updated and expanded with new entries.

Generate actionable results in less than 5 hours

With the MicroSEQ® Rapid Microbial ID System, bacteria and fungi can be identified in less than 5 hours, using a logical workflow that requires minimum hands-on time. A single, standardized procedure is used for identifying both bacterial and fungal isolates. With the data collection analysis software, the system delivers a guided setup process and performs the analysis with limited interaction from the user. No Gram staining or ancillary tests are required to achieve the highest level of accuracy in the minimum amount of time.

Increased throughput with greater ease-of-use

The MicroSEQ® Rapid Microbial ID System powered by the 3500 Series Genetic Analyzer simplifies the user experience and enables faster identifications for the QC laboratory.

  • Plug-and-play capillary array and consumables
  • Consumables dashboard monitor
  • Automated consumable usage tracking
  • Simple on-screen navigation with automated maintenance tracking

Qualify with ease, use with success

To help ensure seamless integration into your laboratory from installation to routine operation, Life Technologies offers comprehensive installation and operational qualification (IQ/OQ) and validation support services. The program includes:

  • Consultation with client to determine needs for training, system installation and validation timelines and plans
  • System software installation, operation, and security verification
  • Installation Qualification (IQ) Protocol and Service
  • Operational (OQ) Qualification Protocol and Service
  • Detailed data analysis and review
  • Consultation on laboratory workflow
  • Performance qualification (PQ)–recommended guidelines

To learn more, visit: www.microseq.com

Webinar: New monitoring methods improve compliance, reduce costs

Date: Tuesday 20 March 2012
Time: 3pm GMT
Length: 1 hour (incl. Q&A session)

Join us for presentations from some of the leading experts in the fields of monitoring and compliance and pharmaceutical water and cleanroom facility standards:

Regulation:
Breaking news on the revision of ISO 14644 and 14698

Water systems:
How to meet EP TOC requirements with an on-line TOC analyzer designed for PAT and Real-Time-Release

Cleanrooms:
New paperless methods solve problems for monitoring airborne particles

Attendees will have the opportunity to ask questions during the Webinar which will be fielded by the presenters during a 15 minute Q&A.

Find out more >>

Bring our NIRSolutions® to your Pharmaceutical Process

The implementation of the process analytical technology (PAT) by the US FDA the effectiveness of the pharmaceutical process increases, the respective cost are reduced and the time to market will speed up. BUCHI offers NIRSolutions® for each customer’s entire production chain, from incoming raw materials qualification to final product release.

Read the full story >>

 

Sanofi and the Institut Pasteur create four prestigious awards to support innovative biomedical research

Sanofi and the Institut Pasteur have created the Sanofi-Institut Pasteur Awards to encourage scientific excellence in the service of health. Four hundred and eighty thousand euro will support four innovative research projects demonstrating real progress in the life sciences and providing answers to major healthcare problems, more specifically in four fields: neglected tropical diseases, vaccine innovation, drug resistance, and therapeutic approaches to ageing and regenerative medicine...

Read full story >>

  Sanofi-Institut Pasteur Awards logo

More pharmaceutical & life science news

Ranbaxy crosses 2bn dollars in global sales
The Board of Directors of Ranbaxy Laboratories Limited, took on record the audited results for the Quarter and Year ended 2011...

Takeda announces acceptance of European Marketing Authorisation application for Peginesatide
An investigational compound for the treatment of anemia associated with CKD...

Roche extends tender offer for Illumina
Roche has extended its cash tender offer to acquire all outstanding shares of Illumina, Inc. at a price of 44.50 dollars per share...

European Commission approves new label for Novartis drug Glivec®
The European Commission has approved an update to the Glivec® (imatinib)* label...

Pfizer acquires Alacer Corp.
Maker of Emergen-C®, #1 U.S. Vitamin C brand, expands Pfizer’s vitamin and dietary supplement business...

Statement on FOSAMAX® (alendronate sodium) Product Liability Trial in New Jersey
Merck will vigorously defend itself in a jury trial set to begin on the 27th February...

Samsung Biologics and Biogen Idec announce formation of biosimilars joint venture Samsung Bioepis
Samsung Biologics & Biogen Idec have established their joint venture...

Abbott collaborates with leading U.S. forensics center on human identification testing
UNT Health Science Center Evaluating Abbott’s PLEX-ID System & Mitochondrial DNA Assay...

Shareholders approve all proposed resolutions of Novartis Board of Directors
Dr. Dimitri Azar elected as new member of the Novartis Board of Directors for a 3yr term...

Pfizer statement regarding CDC’s ACIP discussion of Prevnar 13®
Pfizer believes Prevnar 13 should be recommended for all adults 50 years of age and older...

Boehringer Ingelheim and Xencor enter a collaboration agreement
Antibodies engineered with Xencor’s proprietary Xtend™ technology for increasing antibody half-life...

Featured supplier news

B&W Tek wins their 2nd consecutive annual Reader’s Choice Award
NanoRam™ handheld Raman spectrometer is the winner of the Laboratory Equipment 2012 Reader’s Choice Award...

Bring our NIRSolutions® to your Pharmaceutical Process
The implementation of the PAT by the US FDA the effectiveness of the pharmaceutical process increases...

Tecan Award 2011 winner announced
Tecan is pleased to announce the results of the Tecan Award 2011. Established in 2010 to celebrate the innovation and ingenuity of Tecan’s loyal customers...

The Asia flow chemistry system from Syrris, 320 configuration
Asia flow chemistry system heralds success for Syrris

Syrris is enjoying outstanding success with sales of Asia, its revolutionary range of advanced flow chemistry products.

Conferences, events & exhibitions:

GDDIF 2012
7 - 8 March 2012 Budapest, Hungary

PITTCON 2012
11 - 15 March 2012 Orlando, FL, USA

2nd International Conference of the Flow Chemistry Society
13 - 14 March 2012 Munich, Germany

ADME and Predictive Toxicology
13 - 14 March 2012 Munich, Germany

The Drug Development Process – from Discovery to Commercialization
14 - 16 March 2012 Berlin, Germany

Biomarker Summit 2012
15 - 16 March 2012 San Diego, CA, USA

cGMP Quality Principles for Pharmaceuticals, Biopharmaceuticals, Biologics and Medical Devices
19 - 21 March 2012 Dublin, Ireland

8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
19 - 22 March 2012 Istanbul, Turkey

G Protein-Coupled Receptors in Drug Discovery
20 - 21 March 2012 Berlin, Germany